Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: Long-term benefit of rituximab

Lupus

Volumn 21, Issue 10, 2012, Pages 1124-1127

  Martinez Martinez M U ^a   Abud Mendoza, C ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

diffuse alveolar haemorrhage; rituximab; systemic lupus erythematosus

Indexed keywords

AMLODIPINE; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; ENALAPRIL; HEMOGLOBIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RITUXIMAB;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; CACHEXIA; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CRYOGLOBULINEMIA; DIFFUSE ALVEOLAR HEMORRHAGE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; HYPERTENSION; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; IMPEDANCE; KIDNEY BIOPSY; LONG TERM CARE; LUNG ALVEOLUS; LUNG HEMORRHAGE; LUNG LAVAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CACHEXIA; FEMALE; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PULMONARY ALVEOLI; RECURRENCE; YOUNG ADULT;

EID: 84865092539     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312444171     Document Type: Article

References (16)

1. Martinez-Martinez MU, Abud-Mendoza C. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus. 2011 ; 20: 568-574
2. Liu MF, Lee JH, Weng TH, et al. Clinical experience of 13 cases with severe pulmonary hemorrhage in systemic lupus erythematosus with active nephritis. Scand J Rheumatol. 1998 ; 27: 291-295
3. Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest. 2000 ; 118: 1083-1090
4. Pinto LF, Velasquez CJ, Prieto C, et al. Rituximab induces a rapid and sustained remission in Colombian patients with severe and refractory systemic lupus erythematosus. Lupus. 2011 ; 20: 1219-1226
5. Abud-Mendoza C, Moreno-Valdes R, Cuevas-Orta E, et al. Treating severe systemic lupus erythematosus with rituximab. An open study. Reumatologia Clinica. 2009 ; 5: 147-152
6. Lom-Orta H, Diaz-Jouanen E, Alarcon-Segovia D. Protein-caloric malnutrition and systemic lupus erythematosus. J Rheumatol. 1980 ; 7: 178-182
7. Santos MJ, Vinagre F, Canas da Silva J, et al. Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. Clin Exp Rheumatol. 2011 ; 29: 470-476
8. Todd DJ, Costenbader KH. Dyspnoea in a young woman with active systemic lupus erythematosus. Lupus. 2009 ; 18: 777-784
9. Lee JR, Paik CN, Kim JD, et al. Ischemic colitis associated with intestinal vasculitis: histological proof in systemic lupus erythematosus. World J Gastroenterol. 2008 ; 14: 3591-3593
10. Barber CE, Leclerc R, Gladman DD, et al. Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus. Semin Arthritis Rheum. 2011 ; 41: 353-363
11. Barile LA, Jara LJ, Medina-Rodriguez F, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Lupus. 1997 ; 6: 445-448
12. Rojas-Serrano J, Pedroza J, Regalado J, et al. High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage. Lupus. 2008 ; 17: 295-299
13. Rashidi AA, Alajmi M, Hegazi M. Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report. Lupus. 2011 ; 20: 1551-1553
14. Pinto LF, Candia L, Garcia P, et al. Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody (rituximab). Respiration. 2009 ; 78: 106-109
15. Elazary AS, Klahr PP, Hershko AY, et al. Rituximab induces resolution of recurrent diffuse alveolar haemorrhage in a patient with primary antiphospholipid antibody syndrome. Lupus 2011.
16. Cambridge G, Leandro MJ, Edwards JC, et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum. 2003 ; 48: 2146-2154